BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24510984)

  • 1. MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy.
    Troppan K; Wenzl K; Deutsch A; Ling H; Neumeister P; Pichler M
    Anticancer Res; 2014 Feb; 34(2):557-64. PubMed ID: 24510984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma.
    Martelli M; Ferreri AJ; Agostinelli C; Di Rocco A; Pfreundschuh M; Pileri SA
    Crit Rev Oncol Hematol; 2013 Aug; 87(2):146-71. PubMed ID: 23375551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in lymphoma, from diagnosis to targeted therapy.
    Jardin F; Figeac M
    Curr Opin Oncol; 2013 Sep; 25(5):480-6. PubMed ID: 23852382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.
    Fu K; Iqbal J; Chan WC
    Expert Rev Mol Diagn; 2005 May; 5(3):397-408. PubMed ID: 15934816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
    Lawrie CH; Gal S; Dunlop HM; Pushkaran B; Liggins AP; Pulford K; Banham AH; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS; Harris AL
    Br J Haematol; 2008 May; 141(5):672-5. PubMed ID: 18318758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma.
    Arzuaga-Mendez J; Lopez-Santillan M; Garcia-Ruiz JC; Lopez-Lopez E; Martin-Guerrero I
    Crit Rev Oncol Hematol; 2021 Mar; 159():103247. PubMed ID: 33515703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress of microRNA in diagnosis and prognosis of diffuse large B cell lymphoma-review].
    Yu XN; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1351-5. PubMed ID: 24156464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.
    Roehle A; Hoefig KP; Repsilber D; Thorns C; Ziepert M; Wesche KO; Thiere M; Loeffler M; Klapper W; Pfreundschuh M; Matolcsy A; Bernd HW; Reiniger L; Merz H; Feller AC
    Br J Haematol; 2008 Sep; 142(5):732-44. PubMed ID: 18537969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
    Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
    J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).
    Mazan-Mamczarz K; Gartenhaus RB
    Leuk Res; 2013 Nov; 37(11):1420-8. PubMed ID: 24054860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diffuse large B cell lymphoma: management in 2012].
    Bonnet C; De Prijck B; Lejeune M; Fassotte MF; Van Den Neste E; Beguin Y
    Rev Med Suisse; 2012 Aug; 8(351):1582-4, 1586-90. PubMed ID: 22988711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis in non-Hodgkin lymphoma: implications for therapy.
    Vose JM
    Transfus Apher Sci; 2013 Oct; 49(2):155-6. PubMed ID: 24051218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of diffuse large B-cell lymphoma.
    Lossos IS
    J Clin Oncol; 2005 Sep; 23(26):6351-7. PubMed ID: 16155019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
    Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
    Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
    Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Large-cell diffuse B-cell lymphoma: heterogenous origin and prognosis from the aspect of modern diagnosis].
    Soukup J; Krsková L; Mrhalová M; Kodet R; Campr V; Kubácková K; Trnĕný M
    Cas Lek Cesk; 2003; 142(7):417-22. PubMed ID: 14515445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma.
    Last K; Debarnardi S; Lister TA
    Methods Mol Med; 2005; 115():15-63. PubMed ID: 15998962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies.
    Culpin RE; Sieniawski M; Proctor SJ; Menon G; Mainou-Fowler T
    J Clin Pathol; 2013 Mar; 66(3):249-52. PubMed ID: 23172553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.